Physician
Blumstein, Andrea
Blumstein, Andrea was paid $1.88M by Medicaid between Jan 2018 and Nov 2024, across 141 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 13% of everything it billed.
33Billing provider infoBLUMSTEIN, ANDREA
PARK RIDGE, IL 60068
PARK RIDGE, IL 60068
33aNPI1811989387assigned 08/19/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.88M
24GClaims323,737
24DCodes billed141
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#42 of 398
Median peer was paid$66K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 229 | $3K | |
| 2019 | 716 | $9K | |
| 2020 | 744 | $10K | |
| 2021 | 1,322 | $23K | |
| 2022 | 1,297 | $22K | |
| 2023 | 52,349 | $344K | |
| 2024incomplete | 267,080 | $1.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 13% | 3,774 | 3,627 | $253K |
| 80053 | Comprehensive metabolic panel | 11% | 39,106 | 21,202 | $200K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.1% | 40,033 | 21,926 | $114K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.1% | 434 | 386 | $97K |
| 83735 | 4.2% | 23,233 | 7,198 | $79K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.0% | 18,266 | 6,322 | $75K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.9% | 3,044 | 2,661 | $73K |
| 83880 | 3.6% | 5,298 | 2,868 | $68K | |
| 88141 | 2.8% | 4,244 | 4,081 | $53K | |
| 85027 | 2.7% | 17,754 | 7,021 | $51K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.7% | 2,423 | 2,375 | $50K |
| 87507 | 2.0% | 220 | 212 | $37K |
129 more codes
| 84484 | 1.9% | 8,455 | $35K | |
| 82803 | 1.8% | 3,356 | $33K | |
| 87641 | 1.6% | 1,517 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 3,681 | $30K |
| 85730 | 1.5% | 9,212 | $29K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 1,195 | $27K |
| 84100 | 1.4% | 13,549 | $27K | |
| 86850 | 1.4% | 8,116 | $26K | |
| 87040 | 1.3% | 3,279 | $25K | |
| 88112 | 1.2% | 1,145 | $23K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 1,109 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.2% | 1,104 | $22K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.0% | 4,247 | $19K |
| 85610 | <1% | 9,173 | $18K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 537 | $17K |
| 83605 | <1% | 3,322 | $16K | |
| 84145 | <1% | 928 | $16K | |
| 86901 | <1% | 8,617 | $16K | |
| 83690 | <1% | 4,577 | $15K | |
| 86900 | <1% | 8,616 | $14K | |
| 81001 | <1% | 6,906 | $10K | |
| 88173 | <1% | 239 | $10K | |
| 84702 | <1% | 1,829 | $9K | |
| 82077 | <1% | 790 | $9K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 104 | $8K |
| 80061 | Lipid panel | <1% | 1,684 | $7K |
| 82607 | <1% | 1,152 | $7K | |
| 80202 | <1% | 1,001 | $7K | |
| 86140 | <1% | 2,880 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,968 | $6K |
| 82728 | <1% | 1,447 | $6K | |
| 84439 | <1% | 1,440 | $6K | |
| 85384 | <1% | 1,891 | $6K | |
| 83550 | <1% | 1,419 | $6K | |
| 83615 | <1% | 2,184 | $6K | |
| 87075 | <1% | 960 | $6K | |
| 82746 | <1% | 1,014 | $6K | |
| 85379 | <1% | 1,422 | $5K | |
| 82330 | <1% | 738 | $5K | |
| 87493 | <1% | 229 | $5K | |
| 84703 | <1% | 1,313 | $5K | |
| 87070 | <1% | 1,382 | $5K | |
| 80074 | <1% | 231 | $4K | |
| 87340 | <1% | 695 | $4K | |
| 80143 | <1% | 336 | $4K | |
| 80076 | <1% | 1,028 | $4K | |
| 80179 | <1% | 329 | $4K | |
| 82550 | <1% | 1,356 | $4K | |
| 83970 | <1% | 235 | $4K | |
| 87205 | <1% | 1,891 | $4K | |
| 82140 | <1% | 745 | $4K | |
| 87806 | <1% | 321 | $3K | |
| 86706 | <1% | 549 | $3K | |
| 87210 | <1% | 1,457 | $3K | |
| 86480 | <1% | 123 | $3K | |
| 86704 | <1% | 469 | $3K | |
| 82248 | <1% | 1,693 | $3K | |
| 82570 | <1% | 1,362 | $3K | |
| 86803 | <1% | 349 | $3K | |
| 87483 | <1% | 15 | $3K | |
| 84132 | <1% | 1,346 | $3K | |
| 85046 | <1% | 952 | $3K | |
| 87116 | <1% | 381 | $2K | |
| 87088 | <1% | 508 | $2K | |
| 86592 | <1% | 1,159 | $2K | |
| 86665 | <1% | 139 | $2K | |
| 82533 | <1% | 326 | $2K | |
| 81003 | <1% | 1,869 | $2K | |
| 87015 | <1% | 518 | $2K | |
| 82247 | <1% | 890 | $2K | |
| 87102 | <1% | 542 | $2K | |
| 85652 | <1% | 1,514 | $2K | |
| 89051 | <1% | 647 | $2K | |
| 84481 | <1% | 363 | $2K | |
| 86870 | <1% | 257 | $2K | |
| 86038 | <1% | 265 | $2K | |
| 84478 | <1% | 724 | $2K | |
| 80164 | <1% | 312 | $1K | |
| 81025 | <1% | 478 | $1K | |
| 87653 | <1% | 62 | $1K | |
| 84300 | <1% | 623 | $1K | |
| 86880 | <1% | 449 | $1K | |
| 87206 | <1% | 530 | $1K | |
| 84156 | <1% | 1,067 | $1K | |
| 82010 | <1% | 470 | $1K | |
| 83930 | <1% | 513 | $1K | |
| 83655 | <1% | 210 | $1K | |
| 82150 | <1% | 349 | $1K | |
| 83935 | <1% | 440 | $1K | |
| 84550 | <1% | 477 | $896.21 | |
| 82565 | <1% | 420 | $877.76 | |
| 85018 | <1% | 732 | $725.74 | |
| 86920 | <1% | 176 | $725.21 | |
| 85014 | <1% | 667 | $673.28 | |
| 86308 | <1% | 291 | $669.60 | |
| 85520 | <1% | 130 | $581.49 | |
| 80177 | <1% | 120 | $569.52 | |
| 83010 | <1% | 126 | $553.75 | |
| 86762 | <1% | 105 | $474.12 | |
| 82945 | <1% | 283 | $437.36 | |
| 84157 | <1% | 298 | $395.00 | |
| 86985 | <1% | 94 | $381.30 | |
| 87081 | <1% | 134 | $374.87 | |
| 88342 | <1% | 58 | $351.25 | |
| 85240 | <1% | 62 | $349.56 | |
| 88172 | <1% | 31 | $328.16 | |
| 80069 | <1% | 66 | $281.16 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 16 | $250.88 |
| 87496 | <1% | 13 | $238.85 | |
| 86922 | <1% | 26 | $211.50 | |
| 86645 | <1% | 21 | $174.91 | |
| 82043 | <1% | 78 | $155.51 | |
| 86945 | <1% | 31 | $102.30 | |
| 86664 | <1% | 12 | $94.10 | |
| 82272 | <1% | 62 | $90.92 | |
| 86800 | <1% | 15 | $88.50 | |
| 83993 | <1% | 14 | $86.38 | |
| 84681 | <1% | 13 | $83.33 | |
| 84153 | <1% | 13 | $82.51 | |
| 86765 | <1% | 14 | $65.60 | |
| 85670 | <1% | 27 | $62.91 | |
| 84630 | <1% | 12 | $60.48 | |
| 82270 | <1% | 44 | $59.19 | |
| 84540 | <1% | 29 | $51.04 | |
| 84436 | <1% | 12 | $39.49 | |
| 85461 | <1% | 13 | $34.08 | |
| 84133 | <1% | 13 | $27.30 | |
| 87077 | <1% | 261 | $0.52 | |
| 86923 | 0% | 85 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.